ArticleAlimentary pharmacology & therapeutics2022

Editorial: risk of loss of response to anti TNFα in patients with inflammatory bowel diseases - the longer the less? Authors' reply.

Johannes P D Schultheiss et al.PubMed ↗Publisher ↗

No numbers read from the abstract.